Precision for Medicine Accelerating Precision Oncology with Next-Gen Cancer Screening
Precision for Medicine detailed its NGS initiative which aims to improve the accuracy and speed of identifying cancer mutations in tumors.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Cancer, Sequencing Systems |
Precision for Medicine detailed its NGS initiative which aims to improve the accuracy and speed of identifying cancer mutations in tumors.
Read MorePosted by Chris Wolski | Oct 11, 2022 | Breast, Prostate |
More than two years after the COVID-19 pandemic began, cancer diagnoses continue to lag behind pre-pandemic levels.
Read MorePosted by Andy Lundin | Sep 28, 2022 | Unknown Origin & Other Cancer Types |
The Oncomine Dx Target test was approved as a CDx for a therapy targeting RET-positive thyroid cancer and RET-positive NSCLC.
Read MorePosted by Chris Wolski | Sep 27, 2022 | Cancer, Molecular Diagnostic Analyzers |
UCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
Read MorePosted by Chris Wolski | Sep 14, 2022 | Cancer |
Patients at St. Elizabeth Healthcare can be screened for 50 different types of cancer, thanks to a new cancer-detecting blood test.
Read More